An inducible penicillin j8-lactamase was purified from a strain of Akcaligenes faecalis resistant to ,l-lactam antibiotics. The purified enzyme preparation gave a single protein band on polyacrylamide gel electrophoresis, and its molecular weight was 29,000 based on sodium dodecyl sulfate-acrylamide gel electrophoresis. Its isoelectric point was 5.9. The enzyme more rapidly hydrolyzed penicillins, such as penicillin G, ampicillin, carbenicillin, piperacillin, and cloxacillin, than it hydrolyzed cephalosporins. For the hydrolysis of penicillin G, the optimal pH was 5.5, and the optimal temperature was 35°C. The enzyme activity was inhibited by iodine, Cu2+, Hg2+, and EDTA but was not inhibited by clavulanic acid and sulbactam.
Alcaligenes faecalis, a glucose-nonfermenting, gram-negative rod, has recently been isolated from clinical specimens (13) .
We collected 39 strains of A. faecalis from urinary tract infections and found that most of these strains were resistant to P-lactam antibiotics. P-Lactamase has been considered to be one of the important biochemical mechanisms of resistance to f-lactam antibiotics in bacteria. Many investigations have already described P-lactamase from glucose-nonfermenting, gram-negative rods (2, 11) . However, there have been no reports on the P-lactamase of A. faecalis.
We report here the purification and biochemical properties of penicillinase (PCase) produced by A. faecalis GN14061.
MATERIALS AND METHODS
Bacterial strains. From patients with urinary tract infection, 39 strains of A. faecalis were isolated. All strains were maintained until use at -80°C in skim milk containing 5% glucose (pH 7.4) .
Media. Brain heart infusion broth (Difco Laboratories) and sensitivity disk agar N and sensitivity test broth (Nissui Pharmaceutical Co., Ltd.) were used. Medium B (5) was used for large-scale culture.
Drugs. Penicillin G (PCG), ampicillin, carbenicillin, cloxacillin, cephaloridine, cephalothin, and cefazolin were commercially available materials. We received the following compounds as gifts from manufacturers: piperacillin, cefuroxime, cefotaxime, ceftizoxime, cefoperazone, cefpiramide, aztreonam, clavulanic acid, imipenem, sulbactam, and cefoxitin.
Determination of antibacterial activity. MICs were determined by a standard agar dilution method with sensitivity disk agar N. Of diluted culture (ca. 106 CFU/ml), one loopful (ca. 5 ,ul) in sensitivity test broth was inoculated onto assay media containing serial twofold dilutions of drug. MICs were determined after incubation at 37°C for 18 h.
Inducibility of 1-lactamase production. An overnight culture grown in brain heart infusion broth was diluted 20-fold with medium B and incubated with shaking at 37°C until the * Corresponding author. optical density of the culture at 570 nm reached ca. 0.4 (mid-log phase). PCG was added to a final concentration of 25 ,ug/ml as an inducer for ,B-lactamase production, and incubation was continued. Portions were harvested by centrifugation at 1, 2, 3, 4, and 5 h after the addition of inducer, and ,-lactamase activity in sonically disrupted cells was assayed spectrophotometrically with 200 ,uM PCG as a substrate.
Preparation of crude enzyme. An overnight culture in 500 ml of brain heart infusion broth was diluted 20-fold with medium B and cultured with shaking at 37°C for 2 h. PCG was added as an inducer for P-lactamase production at a final concentration of 400 ,ug/ml, and growth with shaking was continued. After 3 h of incubation, the bacterial cells were harvested by centrifugation at 4°C, washed twice with 50 mM phosphate buffer (pH 7.0), and suspended in the same buffer at 5% of the original volume. The cell suspension was sonicated in an ultrasonic disrupter (UR-150; Tomy Seiko Co., Ltd.) at 75 W for 3 min in an ice bath. The disrupted cell suspension was centrifuged at 30,000 x g for 40 min at 4°C. Streptomycin sulfate was added to the resulting supernatant fluid in a final concentration of 2% (wt/vol) for the removal of nucleic acid. After standing for 10 h, the precipitate was removed by centrifugation, and the supematant was dialyzed against 10 mM Tris-hydrochloride buffer (pH 8.8). The precipitate formed during dialysis was removed by centrifugation, and the resulting supernatant was used as the crude enzyme preparation.
Purification of 3-lactamase. The crude enzyme solution was applied to a DEAE-Toyopearl 650 M column (3.0 by 35 cm) equilibrated with 10 mM Tris-hydrochloride buffer (pH 8.8) . The enzyme was eluted at a flow rate of 80 ml/h with a linear gradient of NaCl from 0 to 0.5 M in a total volume of 400 ml. The active fractions were pooled and concentrated by the addition of polyethylene glycol. The concentrated enzyme solution was loaded onto a Toyopearl HW-55F column (3.0 by 43 cm) and eluted at 50 ml/h with 50 mM phosphate buffer (pH 7.0) containing 0.1 M KCI. The active fractions were dialyzed against distilled water and purified with an ampholine electrofocusing apparatus (model 8100; LKB Instruments, Inc.). Electrofocusing was carried out by using carrier ampholine (pH 3.5 to 10) with a sucrose density gradient at 4°C for 72 h.
Assay for I-lactamase. P-Lactamase activity was determined by a direct spectrophotometric method described previously (2, 6), a modification of the Novick microiodometric method (8 (12, 14) . The purified ,-lactamase showed a unique substrate profile and high activity against penicillin G, ampicillin, carbenicillin, piperacillin, and cloxacillin. The substrate profile of enzyme from A. faecalis GN14061 showed it to be typical of the PCase type; that is, this enzyme did not hydrolyze cephalosporins including cephaloridine, cephalothin, and cefazolin. The substrate profile of the GN14061 enzyme is different from any other PCase types, such as I, II, III, IV, and V (7), TEM types (14) , or PCase type II (9), in cloxacillin and cephaloridine hydrolysis. Although a PCase, its activity was not inhibited by clavulanic acid or sulbactam, which are known to inhibit the activity of PCase (7 (14), and Mitsuhashi and Inoue (7) . Therefore, we consider the enzyme from A. faecalis GN14061 to be a new type of PCase.
